Wed Mar 1, 2000
Wyeth - Ayerst Selects Cryopak as Key Component
For Packaging of Temperature-Sensitive Products
Cryopak Industries Inc. announced today that Cryopak
packing systems have been selected as a key component
in year-round packaging of all temperature-sensitive
products for Wyeth-Ayerst, including its newly announced
vaccine, Prevnar(tm) .
The announcement is the latest development in Cryopak's
three-year relationship with the pharmaceutical giant.
"We are extremely proud of our relationship with
Wyeth-Ayerst and we look forward to the increase in
business that this announcement signals," said John
Morgan, President and CEO of Cryopak Corporation, a
100% owned subsidiary of Cryopak Industries.
Wyeth-Ayerst's vaccine Prevnar(tm) recently received FDA
approval and is the first vaccine to help prevent
pneumococcal disease among young children. Cryopak's
temperature-controlling packing systems have been
identified as playing an important role in the shipment and
transport of this and other pharmaceutical products.
Wyeth-Ayerst Laboratories, a division of American Home
Products Corporation, is a major research-oriented
pharmaceutical company with leading products in the areas
of women's health care, cardiovascular disease therapies,
central nervous system drugs, anti-inflammatory agents,
hemophilia, oncology, vaccines, infectious disease and
generic pharmaceuticals. American Home Products
Corporation is one of the world's largest research-based
pharmaceutical and health care products companies. It is a
leader in the discovery, development, manufacturing, and
marketing of prescription drugs and over-the counter
medications. It also is a global leader in vaccines,
biotechnology, agricultural products, and animal health
care. For more information, visit the company's website at
ahp.com
Cryopak Industries Inc. develops, manufactures and
markets temperature-controlling products and packaging
systems for the transport of pharmaceuticals, seafood,
airline food and beverages, and for Internet directed retail
and commercial shopping networks. The Company is
headquartered in Vancouver, British Columbia and is
traded on the Canadian Venture Exchange under the
symbol CII, and in the U.S., over the counter market, under
the symbol CYPKF. For more information about Cryopak
Industries Inc. or its patented products, visit the Company's
web site at cryopak.com or call toll-free (800)
667-2532.
The Canadian Venture Exchange has not reviewed and
does not accept responsibility for the adequacy or
accuracy of this release.
ON BEHALF OF THE BOARD OF DIRECTORS
Harry Bygdnes
For further information please contact:
Harry Bygdnes, President & CEO, or Adam Rabiner,
Investor Relations
Cryopak Industries Inc. (800) 667-2532 or (604) 685-3616 |
